Rationale: Epigenetic marks are crucial for organogenesis, but their role in heart development is poorly understood. Polycomb repressive complex 2 (PRC2) trimethylates histone H3 at lysine 27, which establishes H3K27me3 repressive epigenetic marks that promote tissue-specific differentiation by silencing ectopic gene programs.
C ongenital heart disease is among the most frequent major birth defects. Intensive studies have revealed numerous genes that control the intricate process of heart development in humans and mice. 1 Prominent among congenital heart disease genes are transcription factors, which points to the important role of transcriptional regulation in orchestrating heart development. 2 Recent studies on the SWI/SNF chromatin remodeling complex have also highlighted the important role of chromatin structure in regulating heart development. 3 In Drosophila, Polycomb group genes genetically antagonize these chromatin remodeling genes. 4 The Polycomb genes Ezh2 (enhancer of Zeste 2), Eed (embryonic ectoderm development), and Suz12 (suppressor of Zeste 12) are major components of the Polycomb repressive complex 2 (PRC2). 5 This highly conserved complex trimethylates histone H3 on lysine 27 (H3K27), which establishes the H3K27me3 epigenetic mark that characterizes transcriptionally repressed chromatin. 4 Through this mechanism, PRC2 regulates tissuespecific differentiation by orchestrating the repression of inappropriate tissue-and stage-specific transcriptional programs. 6 -8 The role of histone methylation or PRC2 in heart development has not been reported.
Here, we used Cre-LoxP technology to conditionally inactivate Ezh2, encoding the catalytic subunit of PRC2, 5, 9 in the developing heart. Cardiac Ezh2 deficiency during a narrow window early in cardiogenesis caused abnormal cardiac gene expression and lethal heart malformations that included hypertrabeculation, thinning of the compact myocardium, and ventricular and atrial septal defects. Our results indicate that establishment of the epigenetic landscape early in cardiogenesis is necessary for normal heart development. Perturbation of this process may contribute to congenital heart disease.
Methods
An expanded Methods section is available in the Online Data Supplement at http://circres.ahajournals.org. Ezh2 fl , Nkx2-5 Lz , TNT-Cre, and Nkx2-5 Cre alleles were described previously. 7,10 -12 Construction of the Eed fl allele will be described elsewhere. All animal experiments were performed according to protocols approved by the Institutional Animal Care and Use Committee of Children's Hospital Boston.
Histological sections were processed as described previously 13 and imaged on an Olympus FV1000 confocal microscope. Antibodies are listed in Online Table I . For morphometric measurements, we measured transverse sections through the atrioventricular valves. Wall thickness was calculated as the ventricular compact myocardial thickness divided by its outer circumference. Trabecular and myocardial area were measured in Adobe Photoshop after selection of image areas with myocardial color range.
Quantitative reverse-transcription-polymerase chain reaction (qRT-PCR) was performed with SYBR green chemistry and normalized to GAPDH. Chromatin immunoprecipitation (ChIP) was performed with antibodies listed in Online Table I . Primers for qRTPCR and quantitative ChIP-PCR (ChIP-qPCR) are provided in Online Table II. RNA analysis by next-generation sequencing (RNA-seq) was performed as described previously, with omission of library normalization steps. 14 Genes were analyzed for differential expression by use of exact tests between 2 negative binomial groups, 15 and the false-discovery rate was calculated by the Benjamini and Hochberg method. ChIP followed by next-generation sequencing (ChIP-seq) was performed as described previously. 16 Libraries were sequenced on an Illumina HiSeq 2000. ChIP-seq peaks were identified by Sole-Search 17 with default parameters. Genomic intervals were annotated, combined, and analyzed for gene ontology term enrichment by use of the completeMOTIFs pipeline. 18 Data were deposited to the Gene Expression Omnibus, accession number GSE29997 and are available at the Cardiovascular Development Consortium Server, http://b2b.hci.utah.edu.
qRTPCR results are expressed as meanϮSEM, whereas ChIPqPCR results are displayed as meanϮSD. Two-group comparisons were performed with Student t test, with PϽ0.05 taken as statistically significant.
Results

Early Cardiac Inactivation of Ezh2 by Nkx2-5
Cre
Disrupts Heart Development
We investigated expression of the PRC2 subunits Eed, Ezh2, and Suz12 in fetal and adult heart. In fetal heart, all 3 subunits were robustly expressed at the mRNA and protein levels ( Figures 1A and 1B) . In adult heart, these transcripts were downregulated, and EZH2 and EED proteins were not detected. Despite reduced Suz12 mRNA, SUZ12 protein was upregulated in adult heart ( Figure 1B ), which suggests posttranscriptional regulation. Immunohistochemistry of E9.5 and E12.5 heart confirmed EZH2 expression in cardiomyocytes and nonmyocytes ( Figure 1C) .
To study the role of PRC2 in heart development, we inactivated an Ezh2 floxed allele (Ezh2 fl ; Shen et al 7 ) in cardiomyocytes using Nkx2-5
Cre . 12 By embryonic day 9.5 (E9.5), Ezh2 fl/fl ::Nkx2-5 Cre/ϩ (abbreviated Ezh2 NK ) cardiomyocytes exhibited markedly reduced EZH2 immunoreactivity ( Figure 1C ). EZH2 expression appeared unchanged in epicardial and endocardial cells, although we cannot exclude Ezh2 inactivation in a subset of these cells. Quantitative PCR confirmed marked Ezh2 depletion in Ezh2 NK mutant hearts ( Figure 1D ). Ezh1, which shows partial functional redundancy with Ezh2, 7 was upregulated in Ezh2 NK mutants ( Figure 1D ). Increased Ezh1 expression may mitigate the severity of the Ezh2 NK phenotype ( Figure 1D ). The major described product of EZH2 methyltransferase activity, H3K27me3, was markedly reduced in Ezh2 NK mutants at E9.5 and E16.5 ( Figure 1E ), consistent with an essential role of EZH2 in H3K27 trimethylation. Ezh2 NK embryos were present at the expected Mendelian ratio at E16.5, but the vast majority died perinatally, so that only 2% of pups at weaning had the mutant genotype ( Figure  1F ). The mutant hearts had 4 chambers, 4 valves, and normal inflow and outflow tract alignment. The ventricular septa were abnormal and exhibited both muscular and membranous septal defects ( Figure 1G ). The compact myocardium (free wall) of both ventricles was hypoplastic, with the right ventricle more severely affected than the left ventricle. Trabeculation of both ventricles was increased. Morphometric measurements confirmed these observations ( Figures 1H  and 1I ). The right atria were markedly dilated, and some mutant hearts had atrial septal defects.
Rare Ezh2 NK mutant mice survived to adulthood. These had persistent hypertrabeculation, right ventricular hypoplasia, atrial and ventricular septal defects, myocardial fibrosis, and moderately impaired left ventricular systolic function ( Figure 2 ).
Decreased Cardiomyocyte Proliferation in Ezh2
NK
Mutant Heart
Hypoplasia of Ezh2 NK compact myocardium suggested reduced cardiomyocyte proliferation. To test this hypothesis, we stained histological sections of E16.5 control and mutant heart for phosphorylated histone H3 (pH3), a cell cycle M-phase marker ( Figure 3A) . Loss of EZH2 caused more than 2-fold reduction in the fraction of pH3 ϩ cardiomyocytes (PϽ0.05; Figures 3A and 3B ). In contrast, we did not detect Figure 3C ). In skin, cultured fibroblasts, and hematopoietic cells, PRC2 directly repressed inhibitors of cyclin-dependent kinase 4 (Ink4) A and B (Ink4a and Ink4b; Mouse Genome Informatics: Cdkn2a/b), powerful negative cell cycle regulators that inhibit the G1-to-S transition. 19, 20 Using ChIP followed by quantitative PCR (ChIP-qPCR), we found that EZH2 and H3K27me3 were enriched at Ink4a and Ink4b promoters of E12.5 heart ventricle ( Figure 3D ). Ink4a and Ink4b were dramatically upregulated in EZH2-deficient ventricle at both E12.5 and E16.5 ( Figure 3E ). Thus, Ezh2 promotes cardiomyocyte proliferation in fetal heart by repressing the negative cell cycle regulators Ink4a and Ink4b.
Abnormal Gene Expression in Ezh2
NK
Mutant Heart
PRC2 promotes lineage-specific differentiation by repressing inappropriate transcriptional programs. To investigate this function of EZH2 in heart, we measured the expression of selected master transcriptional regulators of noncardiac programs by qRTPCR ( Figure 4A ). Pax6, a transcriptional regulator of eye, brain, spinal cord, and pancreas development, 21 was upregulated 49-fold in Ezh2 NK mutant heart. Six1, a homeodomain transcription factor expressed in key progenitor populations, including second heart field, and downregulated in most differentiated tissues, including cardiomyocytes, 22 was upregulated 17-fold in Ezh2 NK mutant heart. Isl1, an essential regulator of cardiac progenitor differentiation, the expression of which is normally downregulated in differentiated cardiomyocytes, 23 was upregulated 7.5-fold. We further confirmed upregulation of ISL1 protein in differentiated cardiomyocytes by immunostaining ( Figure 4B ). Consistent with qRTPCR results, ISL1 immunoreactivity was present in E9.5 Ezh2 NK ventricular cardiomyocytes but not in littermate control cardiomyocytes. Both EZH2 and H3K27me3 were highly enriched at Pax6, Six1, and Isl1 promoters by ChIP-qPCR ( Figure 4C ), which indicates that EZH2 directly represses these genes by establishing H3K27me3 repressive marks.
Cardiac genes undergo an orderly change of expression during cardiomyocyte maturation. Bmp10, which promotes cardiomyocyte growth and ventricular trabeculation, 24, 25 is expressed in compact and trabecular cardiomyocytes at E10.5, becomes restricted to trabecular cardiomyocytes by E12.5, and is no longer expressed in ventricles by E15.5. 24, 25 In Ezh2 NK mutant embryos, Bmp10 expression was upregulated by Ͼ2-fold at both E12.5 and E16.5 ( Figure 4D ).
During cardiac morphogenesis, ventricular cardiomyocytes undergo lineage restriction, repressing genes normally expressed in atrial or conduction system cardiomyocytes. We measured the expression of conduction system-or atriumspecific markers in E16.5 ventricular myocardium. Hcn4, which encodes a cardiac pacemaker channel normally restricted to conduction system myocardium, 26 was upregulated 2.6-fold ( Figure 4D ). The atrium-specific myosin light chain isoform Mlc2a (Mouse Genome Informatics: Myl7) 27 was upregulated 5.3-fold in ventricular myocardium ( Figure 4D ). Consistent with qRTPCR results, MLC2A immunoreactivity was present in E12.5 Ezh2 NK ventricles but not in littermate control ventricles ( Figure 4E ). These results indicate that EZH2 is required to establish normal patterns of gene expression in the developing heart. NK embryos. Hematoxylin-and-eosin-stained transverse sections of E16.5 embryos revealed thinning of compact myocardium (black arrowheads), excessive myocardial trabeculation (blue arrowheads), right atrial dilation, and membranous and muscular ventricular septal defects (double-headed arrows). Scale bar, 500 m. H and I, Thinning of right ventricular and left ventricular compact myocardium and increased myocardial trabecular area. nϭ4 controls and 7 mutants. E indicates embryonic day; P, postnatal day; Expr, expression; mut, mutant; RA, right atrium; RV, right ventricle; LV, left ventricle; and Ctrl, control. *PϽ0.05; **PϽ0.01.
EZH2 and H3K27me3 were moderately enriched at the Hcn4 promoter of wild-type ventricles ( Figure 4F ); however, neither was enriched at Mlc2a or Bmp10 promoters ( Figure  4F ). Thus, EZH2 directly repressed some markers of regionalized cardiac gene expression, whereas its regulation of other such markers was either indirect or occurred through a mechanism other than H3K27me3 deposition.
Genome-Wide Identification of EZH2-Repressed Cardiac Genes
To obtain a global view of EZH2-regulated gene expression in the heart, we measured gene expression and EZH2 and H3K27me3 chromatin occupancy in E12.5 ventricle apex by RNA-seq and ChIP-seq, respectively (Table) . In the RNA-seq experiment, we obtained 32.2 and 31.5 million uniquely aligned 50-nucleotide paired end reads from Ezh2 heterozygous control (Ezh2 fl/ϩ ::Nkx2-5 Cre/ϩ ) and mutant (Ezh2 fl/fl ::Nkx2-5 Cre/ϩ ) hearts, respectively. Expression levels in control and mutant samples were compared on the basis of the density of reads that mapped to each gene. A total of 511 genes were differentially expressed (false-discovery rate Ͻ0.01 and fold change Ͼ50%), including the previously validated genes Ink4a, Six1, Isl1, Pax6, Myh6, Hcn4, and Mlc2a ( Figure 5A ; Online Table III) . These 511 genes were enriched for functional terms related to gland, appendage, ear, and muscle development (Online Table III) .
To identify genes directly occupied by EZH2 and its H3K27me3 repressive mark, we performed ChIP-seq using wild-type E12.5 heart ventricle apex. We obtained 16 to 23 million uniquely aligned 50-nucleotide single end reads in input, EZH2, and H3K27me3 ChIP samples, which led to the identification of 819 and 1052 genes whose promoters were occupied by EZH2 and H3K27me3, respectively (Table;  Online Table IV) . Consistent with EZH2 deposition of H3K27me3 epigenetic marks, in most (697) cases, promoters were co-occupied by both marks ( Figure 5A ). The ChIPqPCR data from Figure 4 independently validated the ChIPseq data: Of the 7 ChIP-qPCR-positive genes, 5 were recovered by ChIP-seq, whereas 2 (Hcn4 and Ink4b) were not. EZH2-and H3K27me3-bound genes had functional annotations related to cell fate commitment, organ morphogenesis, and development of the limbs and skeletal, nervous, and endocrine systems (Online Table IV) .
Next, we looked for the genes that were likely to be directly and functionally regulated by EZH2 through deposi- A, E16.5 heart cryosections stained for TNNI3 and mitosis marker phosphohistone H3 (pH3 tion of H3K27me3. There were 52 genes that were both differentially expressed downstream of EZH2 loss of function and bound by H3K27me3 and EZH2. All 52 of these genes were upregulated in EZH2 loss of function (Fisher exact test PϽ0.0001), as expected for genes directly regulated by EZH2 through establishment of repressive H3K27me3 marks (Figure 5A ; Online Table V) . These 52 EZH2-repressed genes were enriched 14-fold for transcriptional regulators (Pϭ3.9ϫ10 Ϫ9 ; green arrowheads in Figure 5B ) and functional annotations related to gland, limb, forebrain, ear, and heart development (Online Table V ). Among them were Ink4a, Six1, Isl1, and Pax6, identified by the candidate gene approach. The large majority of these showed reduced expression in heart compared with other tissues, such as brain ( Figure 5B ; Online Figure I ).
By analyzing correlations between gene expression in multiple tissues and conditions, in silico we identified tissue-specific gene expression modules and their transcriptional regulators (P.C. and G.Q.D., unpublished data). Components of 3 modules, 1 related to neuronal development and 2 related to fibroblast and mesenchymal-type cells, were overrepresented among genes upregulated in Ezh2 NK (PϽ0.01; Online Table VI) . Key transcriptional regulators of these 3 modules were among the 52 EZH2-repressed genes (Online Table VI ). These data support an essential role of EZH2 in repressing these mesenchymal and neuronal gene programs in cardiomyocytes. 
Later Cardiac Inactivation of Ezh2 by TNT-Cre Is Compatible With Normal Heart Development
Gene inactivation by TNT-Cre occurs in differentiated cardiomyocytes slightly later than Nkx2-5 Cre . 11 Unlike Ezh2
NK mutants, Ezh2 fl/fl ::Tg(TNT-Cre) mutant mice (Ezh2 TNT ) were born at the expected mendelian frequency ( Figure 6A ) and had normal heart structure ( Figure 6B ). Echocardiographic analysis showed no difference in heart function (control fractional shortening 50.5Ϯ2.3% versus Ezh2
TNT fractional shortening 50.7Ϯ0.9%; nϭ7). qRTPCR validated efficient Ezh2 inactivation by E9.5 ( Figure 6C ). The Nkx2-5
Cre knock-in allele is Nkx2-5 haploinsufficient. To exclude Nkx2-5 haploinsufficiency as the cause of the differences observed between Ezh2 NK and Ezh2 TNT mutants, we generated Ezh2 fl/fl ::Tg(TNT-Cre)::Nkx2-5
Lz/ϩ mice. Survival of these mice to weaning was not distinguishable from Ezh2
TNT mice, which indicates that Nkx2-5 haploinsufficiency did not account for the different phenotypes obtained with Nkx2-5
Cre versus TNT-Cre. Although the extent of EZH2 inactivation was similar between Ezh2 NK and Ezh2 TNT by E9.5, Ezh2 NK mutants developed lethal heart defects, whereas Ezh2
TNT mutants did not. We TNT E12.5 heart ventricle, expressed as a ratio to the internal control gene Gapdh. Statistical comparisons were between Ezh2
NK and Ezh2 TNT mutant embryos and between corresponding littermate controls. NS indicates not significant; Ctrl, control; and Mut, mutant. *PϽ0.05; **PϽ0.01; ***PϽ0.001; †not detectable.
compared the effect of Ezh2 inactivation by Nkx2-5
Cre versus TNT-Cre on gene expression in E12.5 ventricle ( Figure 6D) TNT , which suggests that Six1 upregulation by itself did not cause lethal heart malformation in combination with Ezh2 inactivation. Collectively, these data indicate that slightly earlier inactivation of Ezh2 by Nkx2-5
Cre compared with TNT-Cre causes sustained effects on gene expression and heart development.
Ezh2 and the related Ezh1 show partial functional redundancy in some cell types. 7, 28 Functional redundancy between Ezh2 and Ezh1 in the fetal heart may account for the lack of phenotype in Ezh2
TNT mutants. To test this hypothesis, we inactivated the essential, nonredundant PRC2 component Eed with TNT-Cre in fetal cardiomyocytes. In crosses between Eed fl/ϩ :: Tg(TNT-Cre) and Eed fl/fl parents, only 11% of progeny had the Eed fl/fl ::Tg(TNT-Cre) mutant genotype (abbreviated Eed TNT ) at birth, and most mutants died by postnatal day 3, so that only 2% survived to weaning ( Figure 7A ). These data indicated that Eed TNT mutants had perinatal lethal heart defects. Histological sections of late-gestation embryo hearts showed that the mutant compact myocardium was dramatically thinned ( Figure 7B) . By morphometric analysis, the mutant compact myocardium thickness was reduced to 32% that of control myocardium (PϽ0.005, nϭ4; Figure 7C ). Unlike Ezh2 NK mutants, Eed TNT mutants had intact atrial and ventricular septae. Consistent with myocardial thinning, cardiomyocyte proliferation, as assessed by pH3 staining, was strongly reduced (Figures 7D and 7E) . As in Ezh2 NK , Eed TNT mutants exhibited strong upregulation of Ink4a, Ink4b, Isl1, Pax6, and Six1 ( Figure 7F ). Cardiac genes Mlc2a and Hcn4 were also upregulated in Eed TNT , as in Ezh2 NK ; however, Bmp10 was downregulated in Eed TNT , whereas it was upregu- 
lated in Ezh2
NK . These data indicate an ongoing requirement for PRC2 in fetal cardiomyocytes for normal heart growth. This requirement was not reflected in Ezh2
TNT mutants, likely because of functional redundancy with Ezh1.
Discussion
Organ formation requires the establishment and maintenance of tissue-specific gene expression programs in response to developmental cues. This involves both activation of tissuespecific genes and repression of inappropriate genes. By repressing inappropriate gene expression, Polycomb group genes play pivotal roles in cellular differentiation and organ formation. The present results establish the essential role of PRC2 and its subunits EZH2 and EED in orchestrating heart development and cardiac gene expression. Loss of EZH2 in cardiac progenitors and in cardiomyocytes mediated by Cre resulted in lethal heart abnormalities and disrupted cardiomyocyte gene expression. The ongoing requirement for PRC2 activity in cardiomyocytes was reinforced by TNTCre-mediated EED loss of function. Thus, our studies of PRC2 function in the developing heart highlight the key role of histone modifications and the chromatin landscape in regulating cardiac gene expression and heart development.
We identified 52 genes that were directly repressed by EZH2-mediated deposition of H3K27me3. These were highly enriched for transcriptional regulators of noncardiomyocyte gene expression programs, particularly those of neuronal and mesenchymal cells. Expression of these ectopic programs likely contributed to abnormal heart development and function in Ezh2 NK . Interestingly, only a small fraction of genes occupied by EZH2 and H3K27me3 were upregulated by Ezh2 inactivation (52 of 697 genes). This observation may be explained in part by functional redundancy with Ezh1, which showed compensatory upregulation. However, overall H3K27me3 levels were strongly reduced in the Ezh2 NK mutant. This suggests that additional mechanisms besides PRC2-mediated deposition of H3K27me3 maintain repression of the majority of Ezh2/H3K27me3 repressed genes. These additional mechanisms may include establishment of other epigenetic repressive marks, such as DNA methylation. 29 EZH2 and H3K27me3 may participate in initiation of these additional repressive marks but may be dispensable for their maintenance.
One of the major effects of PRC2 loss of function (Ezh2 NK and Eed TNT ) was dramatic thinning of the compact myocardium and decreased cardiomyocyte proliferation. PRC2 inactivation derepressed the potent cell cycle inhibitors Ink4a/b. The strength of Ink4a/b upregulation correlated with myocardial hypoplasia, with Ezh2 NK and Eed TNT mutants exhibiting strong upregulation and Ezh2
TNT mutants showing less substantial upregulation. PRC2 has been shown to repress Ink4a/b and promote cellular proliferation in skin maturation, fibroblasts, and hematopoietic cells, 19, 20 which suggests that this is a common mechanism by which PRC2 regulates proliferation in development and disease.
The normal spatiotemporal regulation of cardiac gene expression was also disrupted in Ezh2 NK mutants. Mlc2a and Hcn4, genes normally confined to the atria and conduction system, respectively, 26, 27 were inappropriately expressed in the mutant ventricle. We also detected upregulation of a third cardiac gene, Bmp10, a secreted regulator of myocardial growth and trabeculation, in Ezh2 NK mutant heart. Mlc2a upregulation was also observed in Eed TNT mutant heart, which suggests that PRC2 acts genetically upstream of this gene to repress its ventricular expression. On the other hand, Bmp10 was downregulated in Eed TNT , which suggests that its regulation by PRC2 is complex. In addition, expression of Bmp10 did not track with myocardial growth phenotypes, because it was also upregulated in Ezh2 TNT (phenotypically normal) and downregulated in Eed TNT (phenotypically similar to Ezh2 NK ). Thus, the pathogenic role of Bmp10 upregulation in Ezh2 NK is uncertain. PRC2 represses gene expression by establishing H3K27me3 epigenetic marks. EZH2 and H3K27me3 were highly enriched at wild-type Ink4a and Ink4b, consistent with an important role for PRC2 in repressing these cell cycle genes. Hcn4 was moderately enriched for H3K27me3 and EZH2 in wild-type ventricle, which suggests that its regulation by EZH2 is also direct. Mlc2a and Bmp10, however, were not substantially enriched for either H3K27me3 or EZH2, which suggests that their regulation by EZH2 was through a mechanism other than direct EZH2 occupancy and H3K27me3 deposition. In fact, the large majority of genes (432 of 511) differentially expressed in EZH2 mutants were not occupied by either EZH2 or H3K27me3, which suggests that either secondary effects lead to their differential expression or that PRC2 regulates them through additional noncanonical mechanisms.
H3K27me3 epigenetic marks serve as docking sites for repressive complexes including the Polycomb repressive complex 1 (PRC1). The PRC1 complex component Polyhomeoticlike 1 (also known as Rae28) was shown to be essential for heart development, in part by sustaining expression of the Nkx2-5. 30 More recently, sumoylation of another PRC1 component, Pc2, was shown to enhance PRC1 recruitment to H3K27me3, and excessive Pc2 sumoylation caused by inactivation of Senp2, which encodes a desumoylating enzyme, was linked to abnormal cardiac development and reduced cardiomyocyte proliferation. 31 Indeed, heterozygous loss of SUMO-1 caused perinatal lethality and cardiac septal defects, and SUMO-1 was required for normal expression of cell cycle genes in the fetal heart. 32 The interplay between sumoylation and Polycomb-mediated gene silencing may be complex, because both EZH2 and SUZ12 have been shown to be sumoylated. 33 The regulation and biological significance of these modifications remain unknown.
Although Ezh2 inactivation by Nkx2-5 Cre caused lethal congenital heart malformations, unexpectedly, its inactivation by TNT-Cre did not. These 2 Cre alleles differ in several ways: (1) timing, with Nkx2-5
Cre being active in cardiac progenitors and TNT-Cre restricted to differentiated cardiomyocytes; (2) Nkx2-5 gene dosage, because of haploinsufficiency in Nkx2-5 Cre ; and (3) recombination domain, with TNT-Cre constrained to differentiated cardiomyocytes and Nkx2-5
Cre potentially additionally including pharyngeal endoderm, endocardium, and epicardium. 12 . Conditional inactivation of the nonredundant PRC2 component Eed by TNT-Cre indicates that PRC2 is required in the TNT-Cre recombination domain, which provides further strong support for this conclusion (see below). Ezh1 has been shown to functionally substitute for Ezh2 in postnatal skin homeostasis 28 and in execution of embryonic stem cell pluripotency. 7 Collectively, these data suggest that Ezh1 and Ezh2 are functionally redundant in cardiomyocytes but not in cardiac progenitor cells (see summary model, Online Figure II) . As a result, there is a small window during which Ezh2 is indispensable in cardiac progenitor cells, and this window is probed by Nkx2-5
Cre but not TNT-Cre. TNT-Cre inactivation of EED recapitulated many aspects of the phenotype observed with Nkx2-5
Cre inactivation of EZH2, including thin compact myocardium and hypertrabeculation; however, Eed TNT mutants had intact cardiac septae, whereas EZH2
NK had both atrial and ventricular septal defects. We believe this difference is caused by the timing of cardiomyocyte inactivation by Nkx2-5
Cre compared with TNT-Cre. First, the majority of nonmyocytes did not undergo Ezh2 inactivation in Ezh2 NK mutants. Second, Eed inactivation with Nkx2-5
Cre did fully recapitulate the EZH2 NK phenotype, including septal defects (A.H. and W.T.P., unpublished data), strongly arguing that both proteins contribute to cardiac septation through the PRC2 complex. Third, inactivation of Eed in endocardium by Tie2Cre did not cause defects in the muscular septae or in myocardial growth (B.Z. and W.T.P., unpublished data). The membranous ventricular septum also constricts normally in these embryos; however, fetal death due to hematologic defects before the time that closure of the membranous septum is normally completed prevented us from fully excluding a role of endocardial PRC2 in formation of the membranous ventricular septum. Together, the data strongly support the model that earlier PRC2 inactivation in cardiomyocytes by Nkx2-5 Cre than by TNTCre causes septal defects during later heart development.
Interestingly, abnormalities in gene expression and chromatin landscape initiated in cardiac progenitor cells as a result of EZH2 loss of function were sustained in cardiomyocytes despite the fact that EZH2 was no longer essential in cardiomyocytes. Later inactivation of EZH2 by TNT-Cre either did not change the expression of these genes or changed them to a lesser degree. This observation likely reflects a form of "epigenetic memory," in which features of the chromatin landscape established under the direction of transient developmental cues are maintained in the absence of those cues. For PRC2-established H3K27me3 marks, this appears to be implemented at a molecular level by mechanisms that recruit PRC2 to preexisting H3K27me3 marks, which leads to maintenance of these marks and their propagation after cell division. 35 Figure II) . Thus, the present results show that transient insults to the chromatin landscape early in embryo development can have delayed and sustained effects on cardiac morphogenesis and gene regulation. This result has strong implications for understanding the pathogenesis of congenital heart disease and may provide new insights into how transient environmental exposures can disrupt organogenesis.
Sources of Funding
This work was supported by funding from the National Institutes of Health (W.T.P., U01HL098166 and R01HL095712) and the American Heart Association (A.H., postdoctoral fellowship 10POST4290028), and by charitable donations from Edward Marram, Karen Carpenter, and Gail Federici Smith.
Novelty and Significance
What Is Known?
• Development of the heart requires tightly choreographed changes in gene transcription.
• Epigenetic histone modifications are essential regulators of gene transcription.
• Polycomb repressive complex 2 (PRC2) catalyzes trimethylation of histone H3 lysine 27 (H3K27me3), a major epigenetic repressive mark.
What New Information Does This Article Contribute?
• PRC2 is essential for normal heart development.
• PRC2 represses noncardiac transcriptional programs and contributes to normal spatiotemporal regulation of cardiac gene expression.
• Perturbation of the epigenetic landscape early in cardiac morphogenesis has sustained disruptive effects at later developmental stages.
Congenital heart disease is one of the most frequent birth defects, and transcription factors are prominent among congenital heart disease genes. Covalent modification of histones is being increasingly recognized as a critical transcriptional regulatory mechanism, but little is known about the role of covalent histone modifications in heart development. In this article, we report on cardiac inactivation of 2 essential subunits of PRC2, the only enzyme known to establish repressive H3K27me3 marks. Our study shows that PRC2 is required for normal heart development. PRC2 was required to repress noncardiac transcriptional programs, as well as potent cell cycle inhibitors and spatiotemporally regulated cardiac genes. Early Nkx2-5 Cremediated inactivation of EZH2, the PRC2 catalytic subunit, caused perinatal lethal heart malformations. Interestingly, later TNT-Cre-mediated inactivation of EZH2 was compatible with normal survival. This was likely because of functional redundancy with EZH1, because TNT-Cre-mediated inactivation of the nonredundant PRC2 subunit Eed also caused lethal heart malformations. Thus, our results demonstrate an essential role for PRC2 and epigenetic transcriptional regulation in heart development. Our data suggest that perturbation of the epigenetic landscape early in cardiogenesis has sustained, disruptive effects at later stages. These results provide new insights into the transcriptional regulation of heart development and the pathogenesis of congenital heart disease.
